GlaxoSmithKline

Quintiles names global head of clinical & data operations

Tuesday, October 11, 2011 10:59 AM

Quintiles has named Steven Skolsky global head of its clinical & data operations (CDO) unit, the core of the company’s clinical development division that monitors the clinical conduct at research sites and collects and manages data from thousands of patients in hundreds of clinical trials conducted around the world.

More... »

GSK seeks $2 billion acquisition in India

Thursday, October 6, 2011 11:58 AM

GlaxoSmithKline is eyeing acquisitions worth as much as $2 billion in India in an effort to cement its position in one of the world's fastest-growing drug markets, the group's chief executive told U.K. newspaper The Times in an interview, according to Dow Jones Newswires.

More... »

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

START expands with phase I center in Shanghai

Thursday, September 22, 2011 10:45 AM

South Texas Accelerated Research Therapeutics (START), a US-based group that claims to run the world’s largest co-ordinated network of phase I clinical trials in oncology, has opened a phase I research facility in China at Fudan University Shanghai Cancer Centre, the city’s largest cancer hospital, according to PharmaTimes.

More... »

Trizzino joins Immunovaccine as CEO

Monday, September 12, 2011 12:44 PM

Immunovaccine has named John J. Trizzino chief executive officer, effective October 1, 2011. Trizzino will also be appointed to the company's board of directors.

More... »

CROs using backlog numbers to put positive spin on less-than-stellar quarterly earnings reports

Monday, August 22, 2011 08:00 AM

Using backlog allows CROs to put a positive spin on what otherwise might be less-than-stellar earnings; while they may not have had the healthiest quarter—or year—financially, they can showcase all of the work that has been promised over the next few quarters in millions, or billions, of dollars.

More... »

DecisionView to launch enrollment-centric metrics

Monday, August 15, 2011 08:00 AM

Clinical trial enrollment-focused software maker DecisionView is launching what it says will be the first benchmarking effort to focus tightly on enrollment metrics.

More... »

GSK signs two-year pact with MolMed

Monday, August 8, 2011 11:49 AM

GlaxoSmithKline's efforts to tackle a rare and often deadly immune deficiency are making progress following a deal signed with Italy's MolMed, according to PharmaTimes.

More... »

GSK CEO predicts R&D success

Friday, July 29, 2011 10:08 AM

GlaxoSmithKline CEO Andrew Witty said the pharmaceutical industry would contract in coming years and that the survivors would be those companies that solved the "equation" of how to squeeze the most profit from every dollar spent on R&D, according to the Philadelphia Inquirer.

More... »

FDA approves Whooping Cough vaccine

Monday, July 11, 2011 12:24 PM

The FDA has approved GlaxoSmithKline’s BOOSTRIXR [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 65 years of age and older for active booster immunization against tetanus, diphtheria and pertussis (whooping cough). This approval makes BOOSTRIX the first Tdap vaccine approved for use in this age group.

More... »